Global Ovulation Disorder Diagnosis Market is segmented By Ovulation Disorders (Polycystic Ovarian Syndrome, Hyperprolactinemia, Luteal Phase Defect, Hypothalamus Dysfunction, Tumours, Autoimmune Oophoritis, Primary Ovarian Failure, Resistant Ovary Syndrome, Others), By Diagnosis (Laboratory Testing of Hormones, CT Scan and MRI Scan of The Pituitary Gland and Hypothalamus, Ovarian Biopsy and others), By End-users (Hospitals, Gynaecological Clinics, and others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029
The Global "Ovulation Disorder Diagnosis Market" is expected to grow at a high CAGR in the forecast period (2022-2029).
- The anovulatory disorder is any condition that affects the normal ovulation process, which is necessary to conceive. There are several causes of ovulation disorders.
- Common causes include hormonal problems when the brain or pituitary gland does not release the correct hormones causing a hormonal imbalance that can be caused by polycystic ovary syndrome (PCOS).
- In some cases, excessive stress, exercise, or weight loss can lead to loss of ovulatory cycles. Some women have premature ovarian failure, and others have ovaries that do not develop because they are resistant to the effects of hormones or have been damaged by medication, radiation, or surgery.
- Women with ovulation disorders are typically given fertility drugs as the first line of treatment. Some of the common causes of ovulation disorders include hyperprolactinemia, hypothalamus dysfunction, luteal phase defect, and tumors of the pituitary or adrenal glands or ovaries.
- Less common causes of ovulation disorders are autoimmune oophoritis (inflammation of the ovaries that results in their destruction), primary ovarian failure, and resistant ovary syndrome.
- Some significant driving factors for the growth of the ovulation disorder diagnosis market include increasing genetic and hormonal disorders, rising obesity rates, the increasing prevalence of diabetes around the world.
- Obese and diabetic females are more prone to the polycystic ovarian syndrome, hence will create a demand for ovulation disorder diagnosis worldwide.
- The increasing adoption of planned pregnancies, decline in fertility rate along with growing awareness of different ovulation disorders among the public further drive this market.
- By Ovulation Disorders, the global ovulation disorder diagnosis market is segmented into polycystic ovarian syndrome, hyperprolactinemia, luteal phase defect, hypothalamus dysfunction, tumors, autoimmune oophoritis, primary ovarian failure, and resistant ovary syndrome, and others.
- Polycystic ovarian syndrome (PCOS) holds the most significant share in the ovulation disorder diagnosis market as it is the most commonly occurring disorder in women.
- This syndrome is caused due to a hormonal imbalance in the body and can be characterized by abnormal menstrual periods and an excess of male hormones. According to the Office of Women’s Health (OWH), polycystic ovary syndrome (PCOS) is a health problem that affects 1 in 10 women of childbearing age.
- By Diagnosis, the global ovulation disorder diagnosis market is segmented into laboratory testing of hormones, CT scan and MRI scan of the pituitary gland and hypothalamus, ovarian biopsy, and others. Laboratory testing of hormones dominates this market segment.
- It is attributed to the fact that most ovulation disorders cause or are caused by hormonal imbalance in the body. Laboratory testing for an ovulation disorder most commonly includes follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, testosterone, and free androgen index.
- Moreover, raising awareness about the benefits of regular check-ups and planned pregnancy will further boost the laboratory testing of hormones share in the diagnosis segment.
- North America is expected to account for the largest revenue share in the ovulation disorder diagnosis market owing to it raising awareness regarding planned pregnancy.
- The high prevalence of PCOS (polycystic ovary syndrome) among North American women and decline in fertility rate and rising first-time pregnancy age are a few of the major factors contributing to the large share of this regional segment as they are bringing more awareness to the various ovulation disorders. Europe is the second-largest market for ovulation disorder diagnosis.
- The Asia Pacific region is expected to be the fastest-growing market for the ovulation disorder diagnosis market as the increasing number of women suffering from lifestyle disorders, increasing healthcare expenditure in these regions are driving the growth of the ovulation disorder diagnosis market. India and China are expected to be the emerging and fastest-growing markets due to the increasing population of these countries.
- To control the growing prevalence of PCOS governments of these countries are focusing on conducting programs that support the diagnosis and therapeutics of PCOS and the needed lifestyle modification. These programs are leading to an increase in awareness of PCOS and risks associated with it, such as the development of obesity, insulin resistance, and in some cases infertility.
- Some of the key players in the ovulation disorder diagnosis market are Siemens Healthcare, Swiss Precision Diagnostics, Toshiba Medical Systems Corporation, Carestream Health, Genova Diagnostics, and Quest Diagnostics.
- The key players are focusing on creating awareness related to ovulation disorder and feminine hygiene through government initiatives in developing regions such as the Asia Pacific, the Middle East, and Africa.
- Other strategies adopted are collaborations and mergers & acquisitions and entering into partnerships to strengthen their position in the market.
Bone Cancer Diagnosis Market
Diagnostic Imaging Equipment Market
Diagnostic Electrophysiology Catheters Market